The role of respiratory tract infections and the microbiome in the development of asthma: A narrative review

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Standard

The role of respiratory tract infections and the microbiome in the development of asthma : A narrative review. / van Meel, Evelien R; Jaddoe, Vincent W V; Bønnelykke, Klaus; de Jongste, Johan C; Duijts, Liesbeth.

I: Pediatric Pulmonology, Bind 52, Nr. 10, 10.2017, s. 1363-1370.

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Harvard

van Meel, ER, Jaddoe, VWV, Bønnelykke, K, de Jongste, JC & Duijts, L 2017, 'The role of respiratory tract infections and the microbiome in the development of asthma: A narrative review', Pediatric Pulmonology, bind 52, nr. 10, s. 1363-1370. https://doi.org/10.1002/ppul.23795

APA

van Meel, E. R., Jaddoe, V. W. V., Bønnelykke, K., de Jongste, J. C., & Duijts, L. (2017). The role of respiratory tract infections and the microbiome in the development of asthma: A narrative review. Pediatric Pulmonology, 52(10), 1363-1370. https://doi.org/10.1002/ppul.23795

Vancouver

van Meel ER, Jaddoe VWV, Bønnelykke K, de Jongste JC, Duijts L. The role of respiratory tract infections and the microbiome in the development of asthma: A narrative review. Pediatric Pulmonology. 2017 okt.;52(10):1363-1370. https://doi.org/10.1002/ppul.23795

Author

van Meel, Evelien R ; Jaddoe, Vincent W V ; Bønnelykke, Klaus ; de Jongste, Johan C ; Duijts, Liesbeth. / The role of respiratory tract infections and the microbiome in the development of asthma : A narrative review. I: Pediatric Pulmonology. 2017 ; Bind 52, Nr. 10. s. 1363-1370.

Bibtex

@article{74cb9ae72c0341aa8f7a39af31f9faca,
title = "The role of respiratory tract infections and the microbiome in the development of asthma: A narrative review",
abstract = "Asthma is a common disease in childhood, and might predispose for chronic obstructive respiratory morbidity in adolescence and adulthood. Various early-life risk factors might influence the risk of wheezing, asthma, and lower lung function in childhood. Cohort studies demonstrated that lower respiratory tract infections in the first years of life are associated with an increased risk of wheezing and asthma, while the association with lung function is less clear. Additionally, the gut and airway microbiome might influence the risk of wheezing and asthma. The interaction between respiratory tract infections and the microbiome complicates studies of their associations with wheezing, asthma, and lung function. Furthermore, the causality behind these observations is still unclear, and several other factors such as genetic susceptibility and the immune system might be of importance. This review is focused on the association of early-life respiratory tract infections and the microbiome with wheezing, asthma, and lung function, it is possible influencing factors and perspectives for future studies.",
keywords = "Journal Article, Review",
author = "{van Meel}, {Evelien R} and Jaddoe, {Vincent W V} and Klaus B{\o}nnelykke and {de Jongste}, {Johan C} and Liesbeth Duijts",
note = "{\textcopyright} 2017 Wiley Periodicals, Inc.",
year = "2017",
month = oct,
doi = "10.1002/ppul.23795",
language = "English",
volume = "52",
pages = "1363--1370",
journal = "Pediatric pulmonology. Supplement",
issn = "1054-187X",
publisher = "JohnWiley & Sons, Inc.",
number = "10",

}

RIS

TY - JOUR

T1 - The role of respiratory tract infections and the microbiome in the development of asthma

T2 - A narrative review

AU - van Meel, Evelien R

AU - Jaddoe, Vincent W V

AU - Bønnelykke, Klaus

AU - de Jongste, Johan C

AU - Duijts, Liesbeth

N1 - © 2017 Wiley Periodicals, Inc.

PY - 2017/10

Y1 - 2017/10

N2 - Asthma is a common disease in childhood, and might predispose for chronic obstructive respiratory morbidity in adolescence and adulthood. Various early-life risk factors might influence the risk of wheezing, asthma, and lower lung function in childhood. Cohort studies demonstrated that lower respiratory tract infections in the first years of life are associated with an increased risk of wheezing and asthma, while the association with lung function is less clear. Additionally, the gut and airway microbiome might influence the risk of wheezing and asthma. The interaction between respiratory tract infections and the microbiome complicates studies of their associations with wheezing, asthma, and lung function. Furthermore, the causality behind these observations is still unclear, and several other factors such as genetic susceptibility and the immune system might be of importance. This review is focused on the association of early-life respiratory tract infections and the microbiome with wheezing, asthma, and lung function, it is possible influencing factors and perspectives for future studies.

AB - Asthma is a common disease in childhood, and might predispose for chronic obstructive respiratory morbidity in adolescence and adulthood. Various early-life risk factors might influence the risk of wheezing, asthma, and lower lung function in childhood. Cohort studies demonstrated that lower respiratory tract infections in the first years of life are associated with an increased risk of wheezing and asthma, while the association with lung function is less clear. Additionally, the gut and airway microbiome might influence the risk of wheezing and asthma. The interaction between respiratory tract infections and the microbiome complicates studies of their associations with wheezing, asthma, and lung function. Furthermore, the causality behind these observations is still unclear, and several other factors such as genetic susceptibility and the immune system might be of importance. This review is focused on the association of early-life respiratory tract infections and the microbiome with wheezing, asthma, and lung function, it is possible influencing factors and perspectives for future studies.

KW - Journal Article

KW - Review

U2 - 10.1002/ppul.23795

DO - 10.1002/ppul.23795

M3 - Review

C2 - 28869358

VL - 52

SP - 1363

EP - 1370

JO - Pediatric pulmonology. Supplement

JF - Pediatric pulmonology. Supplement

SN - 1054-187X

IS - 10

ER -

ID: 185622777